Your browser is no longer supported. Please, upgrade your browser.
Evogene Ltd.
Index- P/E- EPS (ttm)-0.82 Insider Own10.64% Shs Outstand34.15M Perf Week-7.94%
Market Cap139.93M Forward P/E- EPS next Y-0.74 Insider Trans0.00% Shs Float32.19M Perf Month-18.31%
Income-23.40M PEG- EPS next Q-0.18 Inst Own23.90% Short Float2.82% Perf Quarter-63.52%
Sales1.00M P/S139.93 EPS this Y-18.00% Inst Trans0.37% Short Ratio0.90 Perf Half Y34.88%
Book/sh1.35 P/B2.58 EPS next Y-2.80% ROA-35.50% Target Price- Perf Year241.18%
Cash/sh1.20 P/C2.90 EPS next 5Y- ROE-53.50% 52W Range0.94 - 10.24 Perf YTD-25.96%
Dividend- P/FCF- EPS past 5Y-4.10% ROI-51.20% 52W High-66.01% Beta1.30
Dividend %- Quick Ratio5.40 Sales past 5Y-37.80% Gross Margin44.80% 52W Low270.21% ATR0.34
Employees150 Current Ratio5.40 Sales Q/Q300.00% Oper. Margin- RSI (14)35.89 Volatility11.27% 8.69%
OptionableYes Debt/Eq0.05 EPS Q/Q-0.80% Profit Margin- Rel Volume0.31 Prev Close3.30
ShortableYes LT Debt/Eq0.04 EarningsMar 03 BMO Payout- Avg Volume1.01M Price3.48
Recom2.00 SMA20-14.68% SMA50-24.12% SMA200-15.71% Volume314,839 Change5.45%
Dec-01-20Initiated Cantor Fitzgerald Overweight $9
Dec-16-13Initiated Oppenheimer Outperform $26
May-12-21 07:00AM  
Apr-19-21 07:00AM  
Apr-13-21 07:00AM  
Apr-07-21 07:00AM  
Apr-02-21 02:55PM  
Mar-25-21 03:00AM  
Mar-17-21 08:00AM  
Mar-03-21 07:15AM  
Feb-24-21 04:16AM  
Feb-17-21 07:00AM  
Jan-21-21 07:00AM  
Jan-20-21 07:00AM  
Jan-13-21 02:36PM  
Jan-05-21 07:00AM  
Dec-29-20 07:00AM  
Dec-23-20 07:00AM  
Dec-15-20 07:00AM  
Nov-18-20 07:15AM  
Nov-11-20 07:00AM  
Nov-04-20 09:00AM  
Nov-02-20 07:00AM  
Oct-30-20 09:11AM  
Oct-29-20 07:00AM  
Oct-13-20 07:00AM  
Sep-09-20 07:00AM  
Sep-08-20 07:00AM  
Sep-01-20 12:17PM  
Aug-31-20 05:00PM  
Aug-19-20 07:00AM  
Aug-05-20 11:37AM  
Jul-29-20 07:00AM  
Jul-15-20 07:00AM  
Jun-03-20 07:00AM  
May-26-20 07:00AM  
May-20-20 07:00AM  
May-07-20 07:00AM  
May-05-20 07:00AM  
Apr-30-20 07:00AM  
Mar-25-20 08:00AM  
Mar-04-20 07:00AM  
Feb-25-20 07:00AM  
Feb-12-20 07:00AM  
Jan-27-20 07:00AM  
Jan-13-20 07:01AM  
Dec-22-19 06:57PM  
Nov-18-19 07:00AM  
Nov-13-19 07:00AM  
Nov-12-19 07:00AM  
Nov-06-19 07:00AM  
Oct-23-19 07:00AM  
Oct-02-19 07:00AM  
Sep-11-19 07:00AM  
Sep-04-19 07:00AM  
Aug-07-19 07:00AM  
Jul-31-19 07:00AM  
Jul-16-19 07:00AM  
Jul-15-19 07:00AM  
Jul-11-19 07:00AM  
Jul-10-19 07:00AM  
May-28-19 07:24AM  
May-21-19 07:00AM  
May-07-19 07:00AM  
Apr-30-19 07:00AM  
Apr-16-19 07:00AM  
Apr-04-19 10:00AM  
Apr-03-19 01:14PM  
Mar-14-19 07:00AM  
Mar-13-19 07:23AM  
Feb-28-19 07:00AM  
Feb-26-19 07:00AM  
Feb-04-19 07:00AM  
Dec-18-18 07:00AM  
Nov-27-18 07:00AM  
Nov-19-18 08:00AM  
Nov-14-18 07:17AM  
Nov-06-18 08:00AM  
Oct-29-18 07:00AM  
Oct-24-18 07:00AM  
Sep-05-18 07:00AM  
Aug-08-18 07:30AM  
Jul-18-18 07:00AM  
Jul-17-18 07:00AM  
Jul-10-18 07:00AM  
May-31-18 07:30AM  
May-29-18 07:06AM  
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.